Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

GSK plc GSK announced positive data from the phase III ANCHOR-1 and ANCHOR-2 studies, which evaluated its pipeline candidate, ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

Verona Pharma (VRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...

Systemic corticosteroids are used during acute exacerbations and for individuals with poorly controlled end-stage COPD despite being optimally medically managed. All COPD patients who have ...

Study results show that a portable breath analysis device designed for early detection of non–small cell lung cancer may ...

If your healthcare provider suspects you have chronic obstructive pulmonary disease (COPD), you will likely be asked to have a chest X-ray. A chest X-ray is a simple, non-invasive imaging technique ...

Researchers found that respiratory viruses like RSV can persist in lung immune cells long after initial infection, creating ...

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green).

The decision makes Dupixent the first biologic medicine approved in the U.S. for COPD ... succeeded in a Phase 3 trial. Others could join in the coming years, too, as biologic medicines from Roche and ...